Follow
Bacterial infections
Bacterial infections occur when bacteria enter a host, multiply, and incite a reaction in the host's body. Bacteria can enter the host through a variety of areas, such as cuts in the skin or through the airways.
MAR 10, 2022 | 11:55 PM
Several age-related neurodegenerative disorders are characterized by the deposition of aberrantly folded proteins. The histopathological hallmark of synucleinopathies is the deposition of É‘-...
FEB 24, 2022 | 10:00 AM
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
NOV 10, 2021 | 1:30 PM
While clinical microbiology laboratories are pivotal in the identification and handling of infectious diseases, the microbiology lab environment is rapidly changing. Conventional testing met...
OCT 27, 2021 | 10:00 AM
Date: October 27, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The COVID-19 pandemic has brought global awareness to the dangers of emerging pathogens to human health and welfare. Common molecular...
SEP 22, 2021 | 11:00 PM
Neutrophils are the most abundant immune cells in human blood and are crucial for host defense against bacterial and fungal infections. Neutrophils are made mainly in the bone marrow from wh...
SEP 14, 2021 | 9:00 AM
Date: Spetember 14, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Pneumonia remains a major cause of morbidity and mortality. The use of broad-spectrum antibiotics is associated with the developmen...
SEP 09, 2021 | 12:00 AM
Existing methods for antibiotic selection are based on outdated and inaccurate microbiological principles, causing millions of inappropriate antibiotic selections and hundreds of thousands o...
SEP 08, 2021 | 10:30 AM
Varicella zoster virus (VZV) causes two clinically distinct forms of disease, varicella and herpes zoster. These forms can each present with multiple manifestations ranging from lesions incl...
AUG 11, 2021 | 11:00 AM
Date: August 11, 2021 Time: 8:00am (PDT), 11:00am (EDT) Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patie...
JUL 28, 2021 | 7:00 AM
Date: July 28, 2021 Time: 7:00am PDT Bacterial persistence is a potential cause of antibiotic therapy failure. Antibiotic-tolerant persisters originate from phenotypic differentiation within...
JUN 22, 2021 | 10:00 AM
Date: June 22, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Antimicrobial resistance (AMR) has emerged as one of the principal public health problems of the 21st century. It threatens the effectiv...
JUN 07, 2021 | 4:00 PM
DATE: June 7, 2021 TIME: 4:00pm BST. The World Health Organization (WHO) estimates that more than 1 million individuals contract a sexually transmitted infection (STI) every day....
APR 14, 2021 | 3:00 PM
Dr. Jordan RoseFigura from Swift Biosciences will present on the technology created to enable this research that covers 99.7 % of the SARS-CoV-2 genome from limited viral titers. Including a...
APR 08, 2021 | 11:00 AM
Date: April 8, 2021 Time: 11:00am (PDT), 3:00pm (EDT) Pneumonia is a deadly condition with clinical outcomes highly dependent on prompt and appropriate therapy. Diagnosis of pneumonia is cha...
MAR 24, 2021 | 11:00 AM
Date: March 24, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In 2019, roughly 10 million people developed Tuberculosis (TB) globally and 1.4 million of them died, which makes it one of the top 1...
JAN 21, 2021 | 10:00 AM
Date: January 21, 2021 Time: 10:00am (PST) Abstract Learning Objectives Discuss Procalcitonin as a biomarker to help distinguish viral versus bacterial infection Review the literature suppor...
DEC 17, 2020 | 9:00 AM
Date: December 17, 2020 Time: 9:00am (PST), 12:00pm (EST) Correlative light and electron microscopy (CLEM) advances biological discoveries by merging different microscopes and imaging moda...
DEC 04, 2020 | 9:00 AM
Date: December 4, 2020 Time: 9:00am PST, 12:00pm EST Activation of Myeloid cells and interferon release is an early response to infection. The 3-marker combination (CD169/CD64/HLA-DR) gives...
DEC 03, 2020 | 4:30 PM
This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
